Illuminant Surgical has raised $8.4 million in seed funding to accelerate the launch of its Skylight image-based clinical guidance platform.
The platform projects a patient's internal anatomy from medical images directly onto the body surface in real time during procedures. This eliminates the need for surgeons to switch between monitors and the operative field, the company said.
James Hu, MD, (left) and Eldrick Millares (right), co-founders and co-CEOs of Illuminant Surgical.
The Skylight platform combines two proprietary technologies: SkinMatch, a noninvasive patient tracking system using adhesive markers and computer vision to align medical images such as radiographs with patient anatomy in real time, and LightScreen, a depth-adaptive projection system that displays anatomical details directly on the patient's skin, adjusting dynamically for movement and contours.
The platform is initially designed for spine surgery and cancer biopsy procedures, with the company saying it is built to adapt across a broader range of image-guided interventions.
Wing 2 Wing Ventures led the funding round, with participation from the National Science Foundation, National Cancer Institute, National Institute on Aging, and several venture partners.
